Atypical antidepressant

In a nutshell

An atypical antidepressant is any antidepressant medication that acts in a manner that is different from that of most other antidepressants. Atypical antidepressants include agomelatine, bupropion, iprindole, mianserin, mirtazapine, nefazodone, opipramol, tianeptine, and trazodone. The agents vilazodone and vortioxetine are partly atypical. Typical antidepressants include the SSRIs, SNRIs, TCAs, and MAOIs, which act mainly by increasing the levels of the monoamine neurotransmitters serotonin and/or norepinephrine. Among TCAs, trimipramine is an atypical agent in that it appears not to do this. In August 2020, esketamine (JNJ-54135419) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression with the added indication for the short-term treatment of suicidal thoughts.

Related on Lably

Through Medication

Lab · Class 8–12Microorganisms Lab · Class 8Wastewater Story Lab · Class 11NodeMCU & IoT

Buprenorphine/samidorphan (ALKS-5461) is an antidepressant with a novel mechanism of action which was formerly under development and considered an atypical antidepressant. They act faster than available antidepressants.

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human Services Centers for Disease Control and PreventionUnited States government public health agency NauseaMedical symptom or condition SeizurePeriod of symptoms due to excessive or synchronous neuronal brain activity VomitingExpulsion of stomach contents via the mouth or nose Intravenous therapyMedication administered into a vein